Canada markets close in 1 hour 29 minutes

Alliance Pharma plc (APH.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
57.00+1.10 (+1.97%)
At close: 05:07PM BST
Currency in GBp

Valuation Measures4

Market Cap (intraday) 299.60M
Enterprise Value 406.46M
Trailing P/E 24.89
Forward P/E 8.29
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.85
Price/Book (mrq)1.01
Enterprise Value/Revenue 2.49
Enterprise Value/EBITDA 10.62

Trading Information

Stock Price History

Beta (5Y Monthly) 0.46
52-Week Change 3-44.10%
S&P500 52-Week Change 3-14.01%
52 Week High 3122.00
52 Week Low 355.00
50-Day Moving Average 382.28
200-Day Moving Average 3103.27

Share Statistics

Avg Vol (3 month) 32.03M
Avg Vol (10 day) 32.5M
Shares Outstanding 5539.82M
Implied Shares Outstanding 6N/A
Float 8531.88M
% Held by Insiders 114.20%
% Held by Institutions 175.52%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.02
Forward Annual Dividend Yield 43.00%
Trailing Annual Dividend Rate 30.02
Trailing Annual Dividend Yield 30.03%
5 Year Average Dividend Yield 41.62
Payout Ratio 475.83%
Dividend Date 3N/A
Ex-Dividend Date 4Dec 22, 2022
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Jun 30, 2022

Profitability

Profit Margin 7.46%
Operating Margin (ttm)22.15%

Management Effectiveness

Return on Assets (ttm)4.26%
Return on Equity (ttm)4.22%

Income Statement

Revenue (ttm)163.34M
Revenue Per Share (ttm)0.30
Quarterly Revenue Growth (yoy)0.20%
Gross Profit (ttm)109.45M
EBITDA 43.27M
Net Income Avi to Common (ttm)12.18M
Diluted EPS (ttm)0.02
Quarterly Earnings Growth (yoy)59.00%

Balance Sheet

Total Cash (mrq)29.38M
Total Cash Per Share (mrq)0.05
Total Debt (mrq)136.24M
Total Debt/Equity (mrq)45.88
Current Ratio (mrq)1.93
Book Value Per Share (mrq)0.55

Cash Flow Statement

Operating Cash Flow (ttm)33.75M
Levered Free Cash Flow (ttm)33.42M